Modulari-T Biosciences Analysis: $500K Raised
What is Modulari-T Biosciences?
Modulari-T Biosciences develops modular receptors for safer, cost-effective cell therapies targeting cancer and autoimmune diseases.
Founded
2021
Company Stage
Pre-Seed
YC Batch
W23
Product Features & Capabilities
- MARC technology, modular receptors, persistent immune response, complex and logic gated signaling, compatibility across immune cells, compatibility with iPSC/stem cells, scalable and cost-effective.
How much Modulari-T Biosciences raised
1: - $500,000
April 3, 2023Lead Investor: Y Combinator, Pioneer Fund, Metaplanet
Who are the founders of Modulari-T Biosciences
DW
David White
CEO
SM
Investors
- Y Combinator
- Metaplanet
- Pioneer Fund
- Creative Destruction Lab
- MassBio
